Skip to main content
Journal cover image

MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB

Publication ,  Conference
Peters, KB; Affronti, ML; Threatt, S; Healy, P; Herndon, JE; Lipp, ES; Panta, S; Randazzo, D; Friedman, HS; Desjardins, A
Published in: NEURO-ONCOLOGY
November 1, 2017

Duke Scholars

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2017

Volume

19

Start / End Page

206 / 206

Location

San Francisco, CA

Publisher

OXFORD UNIV PRESS INC

Conference Name

Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Affronti, M. L., Threatt, S., Healy, P., Herndon, J. E., Lipp, E. S., … Desjardins, A. (2017). MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. In NEURO-ONCOLOGY (Vol. 19, pp. 206–206). San Francisco, CA: OXFORD UNIV PRESS INC.
Peters, Katherine B., Mary Lou Affronti, Stevie Threatt, Patrick Healy, James E. Herndon, Eric S. Lipp, Sujata Panta, Dina Randazzo, Henry S. Friedman, and Annick Desjardins. “MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB.” In NEURO-ONCOLOGY, 19:206–206. OXFORD UNIV PRESS INC, 2017.
Peters KB, Affronti ML, Threatt S, Healy P, Herndon JE, Lipp ES, et al. MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 206–206.
Peters, Katherine B., et al. “MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB.” NEURO-ONCOLOGY, vol. 19, OXFORD UNIV PRESS INC, 2017, pp. 206–206.
Peters KB, Affronti ML, Threatt S, Healy P, Herndon JE, Lipp ES, Panta S, Randazzo D, Friedman HS, Desjardins A. MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 206–206.
Journal cover image

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2017

Volume

19

Start / End Page

206 / 206

Location

San Francisco, CA

Publisher

OXFORD UNIV PRESS INC

Conference Name

Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences